The State of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update): Anti-Obesity Medications Take Center Stage [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
NASDAQ:AMEX Investor Relations:
ir.actiniumpharma.com
Company Research
Source: Yahoo! Finance
Although the pharmaceutical industry is often labeled as a recession-resistant, it is not immune to future challenges. Ongoing issues such as constraints on drug pricing and reimbursement (P&R), the evolving regulatory landscape, pressures to innovate, and pressures to address environmental, social, and governance (ESG) issues will continue to pose challenges for the pharmaceutical sector in the coming years. In this "The State of the Biopharmaceutical Industry" report, the analyst examines the business environment and trends that are going to shape the biopharmaceutical industry in the next 12 months. Key Market Insights: The biopharmaceutical industry's optimism regarding growth in the next 12 months is on the rise, but still below the levels seen in 2022. A total of 56% of survey respondents shared optimistic or very optimistic sentiment on the biotech funding recovery in 2024. The top-rated industry trends anticipated for the next 12 months include anti-obesity medicati
Show less
Read more
Impact Snapshot
Event Time:
ATNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATNM alerts
High impacting Actinium Pharmaceuticals, Inc. (Delaware) news events
Weekly update
A roundup of the hottest topics
ATNM
News
- Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions [Yahoo! Finance]Yahoo! Finance
- Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials IncreaseGlobeNewswire
- Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking TherapiesGlobeNewswire
- Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML) [Yahoo! Finance]Yahoo! Finance
ATNM
Earnings
- 8/14/23 - Miss
ATNM
Sec Filings
- 4/26/24 - Form 10-Q
- ATNM's page on the SEC website